期刊
JOURNAL OF IMMUNOLOGY
卷 195, 期 1, 页码 105-115出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1402741
关键词
-
类别
资金
- Academy of Finland
- Ella and Georg Ehrnrooth Foundation
- Sigrid Juselius Foundation
- Biocentrum Helsinki
- Biotechnology and Biological Sciences Research Council
- Liv och Halsa Foundation
- Magnus Ehrnrooth Foundation
- Tenovus Scotland
Kindlin-3 is an important integrin regulator that is mutated in the rare genetic disorder, leukocyte adhesion deficiency type III, a disorder characterized by defective neutrophil trafficking and platelet function, leading to recurrent bacterial infections and bleeding. Kindlin-3 is also known to regulate T cell adhesion in vitro and trafficking in vivo, but whether the integrin/kindlin interaction regulates Tor B cell activation in vivo is unclear. In this study, we used TTT/AAA beta(2)-integrin knock-in (KI) mice and TCR-transgenic (OT-II) KI mice, in which the integrin/kindlin connection is disrupted, to investigate the role of the integrin/kindlin interaction in T cell activation. We show that basal T cell activation status in these animals in vivo is normal, but they display reduced T cell activation by wild-type Ag-loaded dendritic cells in vitro. In addition, T cell activation in vivo is reduced. We also show that basal Ab levels are normal in TTT/AAA beta(2)-integrin KI mice, but B cell numbers in lymph nodes and IgG and IgM production after immunization are reduced. In conclusion, we show that the integrin/kindlin interaction is required for trafficking of immune cells, as well as for T cell activation and B cell Ab responses in vivo. These results imply that the immunodeficiency found in leukocyte adhesion deficiency type III patients, in addition to being caused by defects in neutrophil function, may be due, in part, to defects in lymphocyte trafficking and activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据